QuidelOrtho Corp reports results for the quarter ended September 30 - Earnings Summary
QuidelOrtho Corp reported quarterly adjusted earnings of 31 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 80 cents. The mean expectation of three analysts for the quarter was for earnings of 20 cents per share. Wall Street expected results to range from 18 cents to 23 cents per share.
Revenue fell 11.6% to $618.90 million from a year ago; analysts expected $628.13 million.
QuidelOrtho Corp's reported EPS for the quarter was a loss of 78 cents.
The company reported a quarterly loss of $53.8 million.
QuidelOrtho Corp shares had risen by 33.1% this quarter and lost 50.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 76.1% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for QuidelOrtho Corp is $16.00, about 12.3% above its last closing price of $14.03
This summary was machine generated from LSEG data November 3 at 10:02 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 0.20 | 0.31 | Beat |
Jun. 30 2026 | -0.05 | 0.13 | Beat |
Mar. 31 2026 | 0.40 | -0.04 | Missed |
Dec. 31 2025 | 0.42 | 0.46 | Beat |